Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
T-PROSE
Impact of Tongue Proactive Strengthening Exercise Program on Speech and Swallowing Outcomes Following Partial/Hemiglossectomy and Reconstruction
1 other identifier
interventional
40
1 country
1
Brief Summary
This study is being done to determine whether adding a proactive tongue strengthening exercise program using a biofeedback device (the Tongueometer) improves speech and swallowing outcomes after surgery for tongue cancer. Patients who undergo partial or hemiglossectomy often experience difficulties with speech and swallowing, which can significantly impact their quality of life. While speech and swallow therapy is typically provided in response to problems, this study investigates whether introducing structured tongue strengthening exercises with biofeedback early-can lead to better long-term outcomes. This research will help establish whether this approach should become part of standard post-operative care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2025
CompletedFirst Posted
Study publicly available on registry
August 7, 2025
CompletedStudy Start
First participant enrolled
December 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2029
May 7, 2026
May 1, 2026
2.5 years
July 31, 2025
May 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of life patient report outcome (PRO) as assessed by Speech Handicap Index(SHI)
The Speech Handicap Index (SHI), a validated, self-administered questionnaire consisting of 30 items that assess the functional and psychosocial impact of speech disorders. Each item is rated on a 5-point Likert scale (0 = never, 1 = almost never, 2 = sometimes, 3 = almost always, 4 = always). Scores from all items are summed to produce a total score ranging from 0 to 120, with higher scores indicating a greater perceived speech handicap.
6 months post-treatment
Secondary Outcomes (1)
Quality of life patient report outcome (PRO) as assessed by MD Anderson Dysphagia Inventory (MDADI)
6 months post-treatment
Study Arms (2)
Arm 1 - Standard of Care(SOC)
NO INTERVENTIONStandard of Care (SOC): Standard post-operative care with additional intervention if dysarthria or dysphagia symptoms are not improving as expected
Arm 2 - SOC + Interventional Group
EXPERIMENTALSOC + Interventional Group: Standard post-operative care with biofeedback-driven prophylactic tongue strengthening exercise program using the Tongueometer and the routine interventions if dysarthria or dysphagia symptoms are not improving appropriately
Interventions
The Tongueometer device features an air-filled bulb that is placed against the roof of the mouth by the tongue for resistance training. This setup allows for an initial measurement of the patient's maximum tongue strength and endurance, which helps establish goals that are specific to each patient. The device connects to a mobile application that provides visual biofeedback, ensuring consistent monitoring as the patient completes exercises using the tongue bulb for resistance. Once the patient's goals are set based on their initial measurements, the app offers two exercise modules designed to improve both tongue strength and endurance.
Eligibility Criteria
You may qualify if:
- ≥18 years of age
- No prior history of head and neck cancer
- No prior history of radiation
- Planned to undergo resection of ≤50% of the native tongue (partial/hemiglossectomy) with immediate reconstruction, including free flap reconstruction, and with or without neck dissection
- Sufficiently fluent in written English, French, Spanish or Simplified Chinese to complete the study outcomes questionnaires
You may not qualify if:
- Distant metastasis at enrollment
- Previously seen and treated by speech and language pathologist for dysphagia or dysarthria for non-head and neck cancer causes
- Prior head and neck radiation
- Requires mandibulectomy or \>50% resection of native tongue
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Case Comprehensive Cancer Center, Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jamie Ku, MD, FACS
Case Comprehensive Cancer Center, Cleveland Clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2025
First Posted
August 7, 2025
Study Start
December 10, 2025
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
June 1, 2029
Last Updated
May 7, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share